Manulife (Manufacturers Life Insurance)
INFI

Manulife (Manufacturers Life Insurance)’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-23,206
Closed -$26.5K – 3203
2022
Q1 		$26.5K Sell
23,206
-27,097
-54% -$32.4K ﹤0.01% 3057
2021
Q4 		$113 Buy
50,303
+525
+1% +$1.32K ﹤0.01% 3038
2021
Q3 		$170K Sell
49,778
-4,161
-8% -$12.8K ﹤0.01% 3035
2021
Q2 		$161K Buy
+53,939
New +$171K ﹤0.01% 3181
2018
Q3 		– Sell
-2,628
Closed -$5K – 3995
2018
Q2 		$5K Hold
2,628
– – ﹤0.01% 4095
2018
Q1 		$6K Hold
2,628
– – ﹤0.01% 4082
2017
Q4 		$5K Buy
+2,628
New +$5.45K ﹤0.01% 4144
2017
Q3 		– Sell
-1,387
Closed -$2K – 4373
2017
Q2 		$2K Sell
1,387
-9,514
-87% -$18.4K ﹤0.01% 4149
2017
Q1 		$35K Buy
10,901
+9,370
+612% +$23.1K ﹤0.01% 3427
2016
Q4 		$2K Hold
1,531
– – ﹤0.01% 4137
2016
Q3 		$2K Hold
1,531
– – ﹤0.01% 4088
2016
Q2 		$2K Sell
1,531
-32,202
-95% -$151K ﹤0.01% 4034
2016
Q1 		$174K Buy
33,733
+939
+3% +$5.75K ﹤0.01% 2698
2015
Q4 		$257 Hold
32,794
– – ﹤0.01% 2465
2015
Q3 		$277 Buy
32,794
+999
+3% +$9.21K ﹤0.01% 2396
2015
Q2 		$348 Sell
31,795
-282
-0.9% -$3.62K ﹤0.01% 2389
2015
Q1 		$448 Buy
32,077
+994
+3% +$15.2K ﹤0.01% 2154
2014
Q4 		$525 Sell
31,083
-567
-2% -$8.26K ﹤0.01% 1946
2014
Q3 		$425 Sell
31,650
-93
-0.3% -$1.11K ﹤0.01% 2088
2014
Q2 		$404K Sell
31,743
-5,122
-14% -$53.4K ﹤0.01% 2185
2014
Q1 		$438 Buy
36,865
+119
+0.3% +$1.6K ﹤0.01% 2165
2013
Q4 		$508 Sell
36,746
-156
-0.4% -$2.2K ﹤0.01% 2048
2013
Q3 		$644 Sell
36,902
-566
-2% -$10.8K ﹤0.01% 1836
2013
Q2 		$609K Buy
+37,468
New +$1.16M ﹤0.01% 1775

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s INFI Position: Q2 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2022, closing a stake of 23,206 shares — an estimated $26.5K sold.

Manulife (Manufacturers Life Insurance) first reported a position in INFI in Q2 2013 and held it in 24 quarters. The position peaked at $609K in Q2 2013. 77 funds tracked by Wall St. Rank hold INFI as of Q2 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 23,206 Infinity Pharmaceuticals, Inc. shares in Q2 2022, an estimated $26.5K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 24 quarters.
  • Manulife (Manufacturers Life Insurance)'s Infinity Pharmaceuticals, Inc. position peaked at $609K in Q2 2013.
  • 77 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2022, filed 15 Aug 2022.